Skip to main content
Atrás
Watch Compare

Corbus Pharmaceuticals Holdings, Inc.

Calidad de datos: 83%
CRBP
Nasdaq Manufacturing Chemicals
$9.80
▼ $0.52 (-5.04%)
Cap. Mercado: 181.89 M
Precio
$10.26
Cap. Mercado
181.89 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -64.50 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-77.32%
Below sector avg (-53.34%)
ROIC-66.01%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio6.31
Interest CoverageN/A

Valoración

PE (TTM)
-2.32
Below sector avg (-1.47)
P/B Ratio1.97
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -2.3 -1.5
P/B 2.0 1.6
ROE % -77.3 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

9 analistas
Buy
Actual
$9.80
+313.8%
Objetivo
$40.56
$28.00
$38.00
$57.00
Pronóstico
P/E Futuro -2.00
EPS Futuro -$4.90
Ingresos Est. 2.70 M

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$4.90
-$7.99 – -$2.33
 2.70 M 9
FY2026 -$4.66
-$5.74 – -$3.10
 1.25 M 9

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$1.58 -$1.25 +20.7%
Q32025 -$1.71 -$1.90 -11.3%
Q22025 -$1.33 -$1.44 -8.4%
Q12025 -$1.07 -$1.39 -29.6%

ETFs Holding This Stock

VYSVX VYSVX
0.03% weight
GSSC logo GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
0.01% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -78.54 M
ROE -77.32% ROA -66.95%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -64.50 M
ROIC -66.01% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 6.31
Interest Coverage N/A Asset Turnover N/A
Working Capital 90.51 M Tangible Book Value 92.15 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.32 Forward P/E N/A
P/B Ratio 1.97 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -35.46%
Market Cap 181.89 M Enterprise Value 154.90 M
Per Share
EPS (Diluted TTM) -5.90 Revenue / Share N/A
FCF / Share -3.64 OCF / Share -3.64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 82.12%
SBC-Adj. FCF -71.60 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0.0 881,705.0
Net Income -78.54 M -40.21 M -44.60 M -42.35 M -45.64 M
EPS (Diluted) -5.90 -3.68 -10.31 -10.15 —
Gross Profit — — — — —
Operating Income -85.31 M -48.72 M -45.08 M -39.84 M -55.99 M
EBITDA — — — — —
R&D Expenses 70.10 M 32.22 M 31.17 M 16.14 M 36.45 M
SG&A Expenses — — — — —
D&A 233,000.0 588,000.0 640,601.0 762,995.0 999,817.0
Interest Expense 0.0 1.80 M 3.81 M 3.10 M 2.71 M
Income Tax 0.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 168.20 M 155.88 M 28.27 M 66.31 M 107.73 M
Total Liabilities 20.69 M 13.45 M 35.18 M 33.32 M 38.62 M
Shareholders' Equity 147.50 M 142.43 M -6.90 M 32.99 M 69.11 M
Total Debt — — 17.89 M 21.59 M 21.19 M
Cash & Equivalents 28.49 M 17.20 M 13.72 M 17.00 M 25.01 M
Current Assets 166.95 M 152.98 M 23.55 M 60.18 M 100.20 M
Current Liabilities 20.69 M 11.82 M 31.89 M 12.64 M 17.01 M